Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target.
Janeiro MH, Ramírez MJ, Milagro FI, Martínez JA, Solas M. · 2018
Read Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target. by Janeiro MH, Ramírez MJ, Milagro FI, Martínez JA, Solas M. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6213249.txt.
Description
Janeiro and co-authors review a gut-linked molecule called TMAO. Gut microbes make TMAO from choline, betaine, and carnitine. Blood levels depend on diet, gut flora, and liver action. The review appeared in Nutrients. It asks if TMAO is a marker or a drug target.
High blood TMAO links to higher heart event risk. A link to nerve disorders has also been proposed. The authors review food sources and metabolic pathways. They screen studies on heart and brain disease. They discuss the role of inflammation in those links. They also cover ways to cut TMAO levels. Options include antibiotics and new targeted molecules. The authors say TMAO's true role is still unclear.
Catalog record
| CREATOR | Janeiro MH, Ramírez MJ, Milagro FI, Martínez JA, Solas M. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 59 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |